GlassScriptPhysician profile
Christopher J Hall
NPI 1215932397
$2,577.66
in general payments reported to CMS, 2019-2025
19 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2021: $84.64 · 2022: $141 · 2023: $1,282 · 2024: $148 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,082 · Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,082.33 |
| Food and Beverage | $729.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,180.23 | 2023-2025 | Inspire |
| Stryker Corporation | $216.79 | 2019-2022 | |
| Glaxosmithkline, LLC. | $190.23 | 2022-2025 | Nucala |
| Medtronic USA, INC. | $141.50 | 2019 | |
| Integra Lifesciences Corporation | $127.18 | 2019 | |
| Genzyme Corporation | $102.58 | 2025 | |
| Aerin Medical INC. | $98.17 | 2022-2025 | |
| Olympus America INC. | $91.20 | 2019 | |
| Hikma Pharmaceuticals USA | $70.29 | 2024-2025 | Ryaltris |
| Medtronic, INC. | $69.59 | 2021-2024 | Stealthstation S8 Platform |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.32 | 2024-2025 | Relistor |
| Ambu INC. | $51.07 | 2023 | |
| Abbvie INC. | $40.27 | 2022 | |
| Optinose US, INC. | $35.65 | 2019 | |
| Merck Sharp & Dohme LLC | $29.09 | 2021-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $23.61 | 2023 | Vivideo |
| Emd Serono, INC. | $20.19 | 2021 | |
| Kerecis Limited | $16.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Neurent Medical Limited | $11.72 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.